How does morphology impact on diastolic function in hypertrophic cardiomyopathy? A single centre experience

Gherardo Finocchiaro1, Francois Haddad2, Aleksandra Pavlovic1

  • 1Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

BMJ Open
|June 15, 2014
PubMed

Insights

In hypertrophic cardiomyopathy (HCM), diastolic dysfunction is consistently present across all morphological patterns. Left ventricular obstruction, age, hypertrophy, and mitral regurgitation are key factors influencing diastolic dysfunction in HCM patients.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Heart Failure Research

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex condition affecting heart muscle structure.
  • The impact of specific HCM morphologies on diastolic function remains incompletely understood.
  • Diastolic dysfunction is a common complication in HCM, affecting patient prognosis.

Purpose of the Study:

  • To investigate the relationship between diverse HCM morphologies and diastolic function parameters.
  • To identify key clinical and echocardiographic correlates of diastolic dysfunction in a large HCM cohort.
  • To determine if specific HCM patterns are associated with more severe diastolic impairment.

Main Methods:

  • Retrospective analysis of 383 HCM patients with preserved systolic function.
  • Classification of HCM morphology into predefined categories (reverse, sigmoid, symmetric, apical, undefined).
  • Comprehensive echocardiographic assessment of diastolic function (E', E/E', indexed left atrial volume) compared to 100 healthy controls.

Main Results:

  • No significant differences in diastolic dysfunction parameters (E', E/E', LAVi) were observed among different HCM morphologies.
  • All HCM morphologies demonstrated impaired diastolic function compared to controls.
  • Left ventricular (LV) obstruction was a significant independent predictor of diastolic dysfunction, particularly elevated LAVi, E/E', and reduced E'.

Conclusions:

  • Diastolic dysfunction in HCM is prevalent across all morphological types and not significantly influenced by the specific pattern.
  • Key independent predictors of diastolic dysfunction include LV obstruction, patient age, LV wall thickness, and mitral regurgitation severity.
  • These findings highlight the importance of addressing LV obstruction and other contributing factors to manage diastolic dysfunction in HCM.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
813
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
942
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K